CVS/pharmacy kicks off 2014 Project Health campaign
WOONSOCKET, R.I. — CVS/pharmacy announced on Thursday the kickoff of its annual Project Health wellness campaign, which will deliver more than $15 million worth of free health services to multicultural communities across the United States in 2014.
During the months of January, February and March, more than 350 Project Health events will be held at select CVS/pharmacy retail locations in 15 markets across the United States, including Atlanta, Chicago, Cincinnati, Cleveland, Columbus, Dallas-Fort Worth, Detroit, Houston, Los Angeles, Miami, Orlando, New York City, Philadelphia, Tampa and Washington, D.C. Project Health events also will be held at select CVS/pharmacy stores in Puerto Rico in March and April.
Project Health offers free health risk assessments, including blood pressure, body mass index, glucose and total cholesterol screenings. Children 7 years and older may participate in screenings with parental consent. Project Health events also will offer participants’ information on the new health insurance marketplace and their coverage options under the new healthcare law. Health insurance experts will be available at many events to provide guidance and support to those who need it, as they were during the Project Health events held in late 2013. Open enrollment for the health insurance marketplace closes March 31.
"Ninety percent of the people who attended our Project Health screenings in the fall told us they found the health insurance experts at these events to be extremely helpful. For that reason, we decided to offer this resource again in early 2014," stated Helena Foulkes, president of CVS/pharmacy. "We are focused on helping our customers make informed decisions about their health care and will continue to do so as the new healthcare marketplace is rolled out."
Once screened, CVS/pharmacy will help patients through on-site consultations with bilingual (i.e., Spanish- and English-speaking) nurse practitioners or physician assistants who will analyze results and refer patients who require additional medical attention to no-cost or low-cost medical facilities nearby or to their primary care physician if additional follow-up care is necessary. CVS pharmacists will be available to conduct one-on-one medication reviews and answer any questions patients may have.
Hamacher Resource Group enhances category management program to assist independents
WAUKESHA, Wis. — Hamacher Resource Group announced on Thursday that it has enhanced some of the strategies and deliverables of its core monthly category management program, Temps, with a focus on improving the front-end profitability of independent pharmacies.
In addition to introducing two new combination planograms, the company is incorporating even more actionable information in the monthly materials. Examples include breaking down merchandising steps into increments of time so the associate implementing the program can make their efforts most effective in the time available, and highlighting the top-performing subcategories so these sub-sections of the department are sure to receive attention, the company stated. The improvements to the Temps program is designed to help independent pharmacies streamline their front-end to include the SKUs that perform best in the channel and provide higher profit margins.
“We review the Temps program annually and make modifications based on customer feedback and what we’ve learned and observed in the industry,” stated Julie Bonnell, HRG director of operations and member of the owners group. “This year we proactively phone-surveyed our retailer, merchandiser and wholesaler customers, and we used their input to make these more widespread adjustments. We believe the changes, when executed, can positively impact an independent pharmacy’s bottom line.”
According to HRG research conducted in 2012, pharmacists rely on planograms to help manage their front of store. Collaborating with the Healthcare Distribution Management Association and other partners, HRG researched the independent pharmacy market, including interviewing shoppers, reviewing store POS data and surveying pharmacists.
Easton Pharmaceuticals seeking investment in medical marijuana industry
TORONTO — Easton Pharmaceuticals on Thursday announced it is speeding up negotiations with an Ontario-based company toward forming a possible investment/partnership toward their medical marijuana initiatives, which includes participating in their government application for both a growers and distributorship license in Canada and other possible international initiatives.
This company has obtained some private financing, allowing it to recently file an application for licenses and expressed confidence of a government approval; however, that approval is not guaranteed, Easton noted. Additional updates and details on these discussions, including a possible agreement, are expected to be announced shortly.
As of Jan. 1, the world’s first marijuana shops opened for business in Colorado, with more planned for Washington state in the United States. In Uruguay, the first country to legalize marijuana, the government will oversee the sale of marijuana this spring, and in Canada, where public support of marijuana has never been higher, new medical marijuana laws will usher in a free market that produces high-quality cannabis to support a rapidly growing number of users.
In the United States, there are 20 states that permit medical marijuana use with New York state planning to do the same. Two of the 20 states plan to include provisions for recreational use. A recent CNN survey found that 55% of Americans support legalizing marijuana, up from 16% several years ago.
According to a report by the financial news firm See Change Strategy, the medical marijuana industry could conservatively reach nearly $9 billion nationwide in the United States within five years, as more states in the United States clear the way to likely legalize marijuana for medicinal purposes.